Swiss National Bank Annexon, Inc. Transaction History
Swiss National Bank
- $146 Billion
- Q4 2024
A detailed history of Swiss National Bank transactions in Annexon, Inc. stock. As of the latest transaction made, Swiss National Bank holds 135,000 shares of ANNX stock, worth $411,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,000Holding current value
$411,750% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ANNX
# of Institutions
159Shares Held
100MCall Options Held
171KPut Options Held
131K-
Satter Management Co., L.P.7.41MShares$22.6 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$21.4 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.2 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$17.2 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $145M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...